European call for greater HTA co-operation
July 9, 2010Sales and Marketing hta
The European Commissioner who oversees the pharma sector has called for greater co-operation on health technology assessment. John Dalli, the …
Daisy Thomas joins Hill & Knowlton
July 9, 2010Medical Communications Hill & Knowlton, appointment, medical communications
Hill & Knowlton has appointed Daisy Thomas as an account director to its Healthcare & Wellbeing team. She joins from …
Germany raises health premiums to tackle budget deficit
July 9, 2010Sales and Marketing Germany, economic climate, insurance
Chancellor Angela Merkel’s coalition government has agreed to raise health insurance premiums by over half a percent in a further …
Novel anticoagulants set to lead atrial fibrillation market
July 9, 2010Sales and Marketing Brinavess, Multaq, Pradaxa, Xarelto, apixaban, atrial fibrilation
Novel anticoagulants set to capture the atrial fibrillation market by 2019, according to a new report. Analysts Decision Resources say …
Milestone for UK Biobank
July 8, 2010Research and Development DNA, MRC, UK Biobank, Wellcome
Medical research initiative the UK Biobank has collected DNA samples from its 500,000th volunteer, marking a major milestone in its …
Government has mandate for NHS reform, says Dorrell
July 8, 2010NHS, government
In return for ringfencing the NHS’s budget, the government now has a strong mandate for reforming health services, says the …
Pharming forges production deal with Sanofi Chimie
July 8, 2010Manufacturing and Production, Sales and Marketing HAE, Pharming, Ruconest, Sanofi Chimie
Dutch biotechnology group Pharming has signed a toll manufacturing agreement with Sanofi Chimie in order to boost commercial-scale manufacturing of …
Dr Eliseo Salinas joins Elan
July 8, 2010Research and Development Elan, appointment, research and development
Elan has appointed Dr Eliseo Oreste Salinas as executive VP and chief medical officer with responsibility for leading the company’s …
NICE poised to reject Novartis’ Afinitor
July 8, 2010Sales and Marketing Afinitor, NICE, Novartis
Novartis’ kidney cancer drug Afinitor does not offer enough benefit to patients to justify its cost, according to draft guidance …
Digital Pharma: Big pharma’s iPhone apps (part three)
July 7, 2010Medical Communications, Research and Development, Sales and Marketing Apple, Digital Pharma blog, app, ipad, iphone
In the first two parts of Big Pharma’s iPhone Apps I looked at apps produced by 11 of the largest …
Roche submits new version of Herceptin for US approval
July 7, 2010Research and Development, Sales and Marketing Herceptin, Roche, breast cancer
Roche has submitted a new version of its blockbuster Herceptin (trastuzumab) to US regulators for approval to treat advanced breast …
EMA panel advises Fabrazyme switch
July 7, 2010Manufacturing and Production Fabrazyme, Genzyme, manufacturing compliance
Doctors in Europe have been told they should consider switching patients with Fabry disease away from treatment with Genzyme’s Fabrazyme …
Italy plans cancer drug price cut
July 7, 2010Sales and Marketing Italy, economic climate, global pricing, price cuts, pricing
Italy will cut drug prices next year as it adopts a ‘pay for performance’ approach to drug pricing. This will …
George Scangos to head up Biogen
July 7, 2010Research and Development Biogen, appointment, research and development
Biogen Idec has appointed George Scangos chief executive officer, with effect from 15 July. Scangos will join the company from …
4Sight launches conference division
July 7, 2010Medical Communications, Sales and Marketing 4Sight, Performance Meetings, sales and marketing
UK pharma commercial services company 4Sight has launched a conference division. The Bracknell, UK-based firm’s Performance Meetings division will be …
European scrutiny of pharma patent deals to continue
July 6, 2010Sales and Marketing European Commission, competition, patents
Europe’s drug watchdog has served notice that it will keep up scrutiny of pharma patent settlements to ensure they are …
Bind Biosciences appoints Dr Ed Schnipper
July 6, 2010Manufacturing and Production, Research and Development Bind Bioscience, appointment, manufacturing and production, research and development
US biopharmaceutical company Bind Biosciences has appointed Dr Ed Schnipper as chief medical officer. Dr Schnipper joins the company with …
NICE set to block Herceptin for gastric cancer
July 6, 2010Sales and Marketing Herceptin, NICE, Roche, gastric cancer
NICE’s preliminary draft guidance has not approved Roche’s Herceptin for gastric cancer as it failed to show how far the …
NHS slow to tackle health inequalities
July 6, 2010NHS, NHS targets
The NHS has not moved quickly enough to tackle inequalities in life expectancy in areas with the worst health and …
More woe for Genzyme as shipping delays continue
July 6, 2010Manufacturing and Production Cerezyme, Fabrazyme, Gaucher, Genzyme, manufacturing compliance
Genzyme is expecting further delays in shipments of two key products as it struggles to bring its troubled Allston Landing …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
